|
Market Closed -
London S.E.
18:35:02 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 82.50 GBX | 0.00% |
|
0.00% | +2.48% |
| 10-15 | Arecor Therapeutics Obtains Patents in Europe, US, India, for Rapid-acting Insulin | MT |
| 10-15 | Arecor Therapeutics Plc Strengthens Patent Protection For Its Proprietary AT278 Product | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 49.99M | - | - | |||
| 64.69B | |||||
| 54.78B | |||||
| 53.49B | |||||
| 45.98B | |||||
| 42.94B |
Select your edition
All financial news and data tailored to specific country editions
